全文获取类型
| 收费全文 | 1415344篇 |
| 免费 | 116524篇 |
| 国内免费 | 3343篇 |
专业分类
| 耳鼻咽喉 | 18428篇 |
| 儿科学 | 46839篇 |
| 妇产科学 | 41188篇 |
| 基础医学 | 201663篇 |
| 口腔科学 | 37950篇 |
| 临床医学 | 126791篇 |
| 内科学 | 285426篇 |
| 皮肤病学 | 33447篇 |
| 神经病学 | 117556篇 |
| 特种医学 | 54068篇 |
| 外国民族医学 | 464篇 |
| 外科学 | 211661篇 |
| 综合类 | 32989篇 |
| 现状与发展 | 3篇 |
| 一般理论 | 515篇 |
| 预防医学 | 110565篇 |
| 眼科学 | 31597篇 |
| 药学 | 99147篇 |
| 1篇 | |
| 中国医学 | 3351篇 |
| 肿瘤学 | 81562篇 |
出版年
| 2021年 | 10927篇 |
| 2019年 | 11765篇 |
| 2018年 | 16690篇 |
| 2017年 | 12755篇 |
| 2016年 | 14346篇 |
| 2015年 | 16095篇 |
| 2014年 | 22741篇 |
| 2013年 | 33651篇 |
| 2012年 | 45709篇 |
| 2011年 | 48262篇 |
| 2010年 | 28350篇 |
| 2009年 | 27252篇 |
| 2008年 | 44647篇 |
| 2007年 | 47206篇 |
| 2006年 | 47740篇 |
| 2005年 | 46232篇 |
| 2004年 | 44096篇 |
| 2003年 | 42001篇 |
| 2002年 | 40466篇 |
| 2001年 | 73255篇 |
| 2000年 | 74749篇 |
| 1999年 | 61766篇 |
| 1998年 | 17092篇 |
| 1997年 | 15498篇 |
| 1996年 | 15657篇 |
| 1995年 | 14861篇 |
| 1994年 | 13466篇 |
| 1993年 | 12656篇 |
| 1992年 | 46020篇 |
| 1991年 | 43649篇 |
| 1990年 | 41655篇 |
| 1989年 | 39718篇 |
| 1988年 | 36341篇 |
| 1987年 | 35524篇 |
| 1986年 | 33019篇 |
| 1985年 | 31442篇 |
| 1984年 | 23946篇 |
| 1983年 | 20120篇 |
| 1982年 | 12288篇 |
| 1981年 | 10849篇 |
| 1979年 | 20788篇 |
| 1978年 | 14640篇 |
| 1977年 | 12141篇 |
| 1976年 | 11437篇 |
| 1975年 | 11678篇 |
| 1974年 | 14055篇 |
| 1973年 | 13609篇 |
| 1972年 | 12708篇 |
| 1971年 | 11520篇 |
| 1970年 | 10947篇 |
排序方式： 共有10000条查询结果，搜索用时 78 毫秒
221.
222.
Growth Hormone Induces Recurrence of Infantile Hemangiomas After Apparent Involution: Evidence of Growth Hormone Receptors in Infantile Hemangioma 
下载免费PDF全文
下载免费PDF全文 Naikhoba C. O. Munabi B.A. Qian Kun Tan H.S. Maria C. Garzon M.D. Gerald G. Behr M.D. Carrie J. Shawber Ph.D. June K. Wu M.D. 《Pediatric dermatology》2015,32(4):539-543
Infantile hemangiomas (IHs) are the most common benign tumor of infancy, characterized by a natural history of early proliferation in the first months of life to eventual involution during childhood, often with residual fibrofatty tissue. Once involution has been achieved, IHs do not typically recur. We present two cases of exogenous growth hormone therapy resulting in the recurrence of IHs in late childhood, supported by radiological, immunohistochemical, in vitro, and in vivo evidence. 相似文献
223.
224.
225.
226.
227.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
228.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献229.
Bimal Bhindi Christine M. Lohse Phillip J. Schulte Ross J. Mason John C. Cheville Stephen A. Boorjian Bradley C. Leibovich R. Houston Thompson 《European urology》2019,75(5):766-772
Background
Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.Objective
To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.Design, setting, and participants
In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.Intervention
RN and PN.Outcome measurements and statistical analysis
Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal , which ranges from 0 to 1, with higher values indicating increased predictive ability.Results and limitations
The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal ). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal ). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.Conclusions
We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.Patient summary
We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors. 相似文献230.
I. Fouzas C. Papanikolaou G. Katsanos N. Antoniadis N. Salveridis K. Karakasi S. Vasileiadou A. Fouza E. Mouloudi G. Imvrios V. Papanikolaou 《Transplantation proceedings》2019,51(2):416-420